Dor Pharmaceutical Services

Name

Dor Pharmaceutical Services

Legal name

Novolog (Pharm Up 1966) Ltd.

Website

https://dor-ps.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Regulatory Services

NAICS

Professional, Scientific, and Technical Services (54), Scientific Research and Development Services (5417), Management Consulting Services (54161)

SIC

Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

akta.pro secondary industry

Manufacturing, MSAT & Operations Staffing (API/Biologics/Cell & Gene) (HLAGAOAL)

Keywords

• Pharmaceutical regulatory services
• Quality assurance consulting
• Medical device compliance
• Pharmacovigilance services
• Clinical trial coordination

Headquarters

HQ city

Modi'in

HQ country

Israel

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Regulatory Affairs and Registration Services: On-demand regulatory affairs outsourcing, including new drug registration, registration maintenance, appointed pharmacist services, and Marketing Authorization Holder (MAH) services for pharmaceutical, medical device, medical cannabis, cosmetics, and food supplement companies in Israel.
2. QP and QA Services: Qualified Person (QP) certification, batch release services, and ongoing quality assurance management to help companies comply with GMP guidelines and Israeli Ministry of Health regulations.
3. Labeling, Translation, and Printing Services: End-to-end product labeling and localization, including translation, graphic design, proofreading, and printing of packaging materials (leaflets, labels, folding cartons) for pharmaceutical, medical device, cosmetics, and food supplement products.
4. Pharmacovigilance and Medical Information Services: Provided through sister company Medicalix, covering adverse event reporting, device vigilance, medical information, contact center services, and QPPV services for both marketed and clinical trial products.
5. Clinical Trial Services: Full outsourcing of clinical trial coordination at leading Israeli medical centers, including protocol translation, informed consent form translation, regulatory submissions, and supply chain management.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Core offering

Dor Pharmaceutical Services is an Israeli B2B regulatory and quality services provider that supports pharmaceutical, medical device, medical cannabis, cosmetics, and food supplement companies with new drug registration, registration maintenance, Qualified Person (QP) and Quality Assurance (QA) services, GMP-certified labeling/translation/printing, pharmacovigilance, and clinical trial coordination. The company operates an outsourced regulatory affairs department model that extends or fully replaces client regulatory and QA teams on a flexible, on-demand basis, and serves as a one-stop-shop for navigating Israeli Ministry of Health requirements.

Product overview

Dor Pharmaceutical Services is a comprehensive regulatory and quality services company offering a unified platform of pharmaceutical services. The core offerings include Regulatory Affairs and Drug Registration, Qualified Person (QP) and Quality Assurance (QA) Services, Labeling/Translation/Localization with an in-house GMP printing plant, Clinical Trials Services, and Pharmacovigilance Services. The company operates across five industry verticals: Pharmaceuticals, Medical Devices (AMAR), Food Supplements, Cosmetics, and Medical Cannabis. Services range from new product registration and quality compliance to labeling production and clinical trial coordination. The company is part of Novolog Group's logistics division and serves over 300 customers since its founding in 2011.

Differentiator

Problem solved

Functional benefit

Brands

• Medicalix: A sister company of Dor Pharmaceutical Services specializing in pharmacovigilance, device vigilance, and medical information services.

Products and services

• Regulatory Affairs and Drug Registration Comprehensive regulatory services for obtaining marketing authorization for pharmaceutical products in Israel, including new drug registration, dossier examination, regulatory compliance, and registration maintenance for both innovative and generic drug manufacturers.
• Qualified Person (QP) and Quality Assurance (QA) Services Certified QP batch release and QA services helping companies meet GMP guidelines and Israeli Ministry of Health regulations, including batch release, quality system establishment, GMP/GDP audit support, and ongoing quality management.
• Labeling, Translation and Localization Services End-to-end product labeling and localization including translation into Hebrew, English, Arabic, and Russian, graphic design, proofreading via Global Vision technology, and printing of packaging materials (leaflets, labels, folding cartons) at the GMP-certified printing plant.
• Clinical Trials Services Full outsourcing services for coordinating clinical trials at leading Israeli medical centers, including protocol translation, informed consent form preparation, regulatory submissions, and supply chain management.
• Pharmacovigilance Services Adverse event reporting and monitoring services for pharmaceutical products and medical devices, including device vigilance, medical information, contact center services, and QPPV services for both marketed and clinical trial products, delivered through sister company Medicalix.
• Medical Cannabis Regulatory Services Specialized regulatory services for Israeli medical cannabis companies covering facility establishment, validations, IMC-GMP certification, pharmacy services, product registrations, packaging materials, quality assurance, and clinical research for cultivation, production, distribution, and pharmacy operators.
• Cosmetics Regulatory Services Regulatory affairs support for cosmetics in Israel, including product registration, labeling compliance, safety assessments, Product Information File (PIF) management, and support for adapting to the new Israeli Ministry of Health cosmetics directive and EC Regulation No 1223/2009.
• Food Supplements Regulatory Services Comprehensive regulatory solutions for food supplement manufacturers, importers, and distributors to obtain product regulatory approval in Israel, covering dietary supplements, vitamins, nutritional supplements, herbal products, and homeopathic remedies.
• Medical Devices Regulatory Services Focused regulatory solutions for medical device companies covering Israeli and international requirements, including AMAR (Medical Device Registration) with Israeli Ministry of Health, ISO 13485 compliance, device classification, import/export regulatory affairs, and quality management system support across all device classes.
• GMP Printing and Relabeling Facility GMP-certified printing facility providing healthcare product labeling, including relabeling services and offset and digital printing on various substrates under cGMP, Israeli Ministry of Health, and multinational pharma company guidelines, managed by a qualified pharmacist and controlled by quality bodies.

Quantifiable outcome

• Successfully accompanied IMC-GMP audits under new regulations for medical cannabis companies
• +1 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• Novolog Group (נובולוג)coreOthersDor is part of the Logistics Division of Novolog Group (TASE: NVLG), a senior strategic logistics partner of global pharma companies operating in Israel. Novolog Group employs more than 800 people and provides healthcare logistics, import, and distribution of medicines and medical devices, home healthcare and personalized healthcare, and medical information digital services.
• MedicalixcoreTechnology or IntegrationMedicalix is Dor's sister company and the leading pharmacovigilance service provider in Israel. Dor outsources its pharmacovigilance (PV), device vigilance, and medical information (MI) services through Medicalix, enabling companies to comply with applicable local regulations for both marketed and clinical trial products.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Regintel Consulting: Regintel is a smaller regulatory affairs consultancy serving pharma and consumer health companies. Comparable to Dor's regulatory service offering but with narrower geographic and therapeutic reach.
• Biologics Consulting Group: Biologics Consulting Group provides regulatory, quality, and compliance consulting to biologics, pharmaceutical, and medical device companies. Overlaps with Dor's RA and QA offerings but focuses more on FDA-facing regulatory work in the US market.

Direct peers

• Arriello: Arriello is a regulatory affairs, pharmacovigilance, and quality/compliance consultancy for pharma, biotech, and medical device companies across Europe and Israel. Closely comparable to Dor in service mix (RA, QP/QA, PV, labeling) and customer profile, with similar geographic focus.
• The Weinberg Group: The Weinberg Group is a regulatory and quality compliance consulting firm serving pharma, biotech, and medical device clients. Directly comparable to Dor on regulatory affairs and quality assurance service lines for healthcare product manufacturers.

Broad incumbents

• ICON plc: ICON plc is a global CRO and healthcare intelligence company offering clinical, regulatory, and laboratory services. Comparable to Dor on regulatory submissions and clinical trial coordination, with much broader geographic and service coverage.
• ProPharma Group: ProPharma Group provides regulatory affairs, compliance, clinical research, and pharmacovigilance consulting to pharma and medical device companies. Overlaps directly with Dor's RA, QA, and PV services, but with much broader international reach.
• PharmaLex (Cencora): PharmaLex, now part of Cencora, is a global regulatory affairs, quality management, and pharmacovigilance services provider. Comparable to Dor across RA, QP, and PV service lines, but at much larger scale and broader geographic footprint, including Israel presence.
• Parexel International: Parexel provides biopharmaceutical services including regulatory consulting, clinical research, and pharmacovigilance. Competes with Dor for RA and PV engagements from global pharma and medical device manufacturers, with deeper regulatory expertise across major markets.
• IQVIA: IQVIA is the largest global provider of clinical, regulatory, and commercial services to life sciences companies. Competes with Dor for regulatory affairs and pharmacovigilance engagements, particularly on global master service agreements, though at vastly larger scale.

Others

• Tarius: Tarius is a regulatory intelligence platform covering 100+ countries with a network of 300+ regulatory specialists, already a partner of Dor's. Functions as an enabling technology/intelligence vendor to Dor's regulatory affairs practice rather than a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Novolog-Group-285353635695351
• LinkedInlinkedin.com/company/dor-pharmaceutical-services
• Xx.com/doravner

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dor Pharmaceutical Services